MONTE ROSA THERAPEUTICS INC (GLUE) Institutional Ownership and Insiders Activity

MONTE ROSA THERAPEUTICS INC (GLUE) is widely held by institutional investors, with 187 firms reporting positions valued at approximately $2.22B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Price T Rowe Associates Inc is the largest disclosed holder, reporting approximately $214.44M in GLUE holdings in its latest filing.

Recent insider activity includes 15 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.